Mulmit

VOLITIONRX LTDVOLITIONRX LTD

VNRX NYSE

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-311,727,384-21,738,571-23,357,027
2024-12-311,233,511-27,024,970-26,967,836-0.31
2023-12-31775,302-35,987,695-35,677,074-0.5
2022-12-31306,392-31,780,072-30,598,469
2021-12-3190,035-28,333,079-26,989,781

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-03-17Forterre GaelChief Commercial Officer5,251
2026-03-17Rootsaert Rodney GerardSecretary3,948
2026-03-17Plummer NicholasGC - Volition Diagnostics7,003
2026-03-17Micallef Jacob VincentChief Scientific Officer5,310
2026-03-01Rootsaert Rodney GerardSecretary3,321
2026-03-01Forterre GaelChief Commercial Officer2,283
2026-03-01Plummer NicholasGC - Volition Diagnostics5,867
2026-02-26Forterre GaelChief Commercial Officer149,000
2026-02-26Rubin Ethel178,000
2026-02-26Reynolds Cameron JohnPresident and CEO486,000
2026-02-26Batchelor Ann-LouiseGroup Chief Marketing Officer142,000
2026-02-26Hughes TerigChief Financial Officer202,000

8-K events

FiledItems
2026-09-02Entry into a material agreement · Financial statements and exhibits
2026-09-02Unregistered sales of equity securities
2026-08-24Unregistered sales of equity securities
2026-08-13Results of operations · Financial statements and exhibits
2026-08-07Unregistered sales of equity securities
2026-07-21Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-06-18Unregistered sales of equity securities
2026-06-10Entry into a material agreement · Other events · Financial statements and exhibits
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

In Vitro & In Vivo Diagnostic Substances — 같은 업종, 그리고 규모가 비슷한 기업In Vitro & In Vivo Diagnostic Substances — and other companies of a similar size

SEC가 같은 업종(In Vitro & In Vivo Diagnostic Substances)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (In Vitro & In Vivo Diagnostic Substances) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.